Study supports early use of antifungal therapy in NICU babies

04/6/2012 | Medscape (free registration)

Empiric antifungal therapy should be considered before blood culture results are available for extremely low birth weight babies at high risk of invasive Candida to help prevent death or neurodevelopmental impairment, researchers reported in The Journal of Pediatrics. Duke University researchers said Candida species are a leading cause of death in NICUs and waiting for blood culture results could take days and have fatal consequences.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD